Myocardial InfarctionNCT00188123
Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)
An observational study of Myocardial Infarction, run by University Hospital, Linkoeping at 1 site in Sweden.
Trial summary
The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique Read more about this study
- Who is it for?
- Ages 20 to 80 years
- Conditions the study is for
- Myocardial Infarction
- How many people
- 20 participants
- Where
- 1 siteSweden
- Study dates
- Apr 2004to Apr 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patient with an in-hospital diagnosis of myocardial infarction having permanent atrial fibrillation.
Who may be able to join
- in-hospital diagnosis of myocardial infarction
Who cannot join
- pacemaker, not willing to participate, metallic objects in brain or eyes,
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI
The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique
Read the detailed description
50 outpatients in Jonkoping County with a diagnosis of in-hospital myocardial infarction, are asked to participate in this study comparing segmented true FISP late enhancement with single-shot trueFISP late enhancement for the diagnosis of myocardial damage. The study does not intervene regarding treatment but is a comparison of the diagnostic power of the two MRI techniques.
- Conditions
- Myocardial Infarction
- Keywords
- Myocardial infarction, MRI late enhancement, Atrial fibrillation
- Medical subject headings
- Myocardial Infarction, Atrial Fibrillation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2005 (estimated)
- Study startApr 2004
- Primary completionSep 2005
- Study completionApr 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Linkoeping
- Sponsor type
- University, hospital or other
- Collaborators
- Jonkoping County Hospital, Medical Research Council of Southeast Sweden
- Investigators
- Jan E Engvall, MD, PhD, Principal investigator, University Hospital, Linkoeping
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00188123
- Sponsor's protocol ID
- 151:2004/8333 MPA Sweden
- Status last verified
- Sep 2005
- First submitted
- 15 Sep 2005
- Last updated
- 15 Jul 2009
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Jul 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI
- ClinicalTrials.gov ID
- NCT00188123
- Acronym / sponsor ID
- 151:2004/8333 MPA Sweden
- Conditions
- Myocardial Infarction
- Keywords
- Myocardial infarction, MRI late enhancement, Atrial fibrillation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University Hospital, LinkoepingUniversity, hospital or other
- Collaborators
- Jonkoping County Hospital, Medical Research Council of Southeast Sweden
- Study start
- Apr 2004
- Primary completion
- Sep 2005 (actual)
- Study completion
- Apr 2009 (actual)
- First posted
- 16 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique
Detailed description
50 outpatients in Jonkoping County with a diagnosis of in-hospital myocardial infarction, are asked to participate in this study comparing segmented true FISP late enhancement with single-shot trueFISP late enhancement for the diagnosis of myocardial damage. The study does not intervene regarding treatment but is a comparison of the diagnostic power of the two MRI techniques.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patient with an in-hospital diagnosis of myocardial infarction having permanent atrial fibrillation.
Key inclusion criteria (1 listed)
- in-hospital diagnosis of myocardial infarction
Key exclusion criteria (1 listed)
- pacemaker, not willing to participate, metallic objects in brain or eyes,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jul 2009.
Related trials for Myocardial Infarction
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Enrolling by invitation
The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention
Coronary Atherosclerosis and Other Heart Disease, Cardiovascular Diseases
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jan E Engvall, MD, PhD principal investigator
University Hospital, Linkoeping
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myocardial Infarction, run by University Hospital, Linkoeping at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jul 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2009.